Clinical Study

An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable

Posted Date: Jan 27, 2020

  • Investigator: Caleb Adler
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Drug

A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia


Tv46000-Cns-30072 (Roll-Over Participant) Or A New Participant Who Did Not Participate In The Tv46000-Cns-30072 Study


Adult, Adolescent, Schizophrenia

For More Information:

Karen Tugrul, Bsn, Rn

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.